Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
219 hedge funds and large institutions have $1.93B invested in Arena Pharmaceuticals Inc in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 79 increasing their positions, 68 reducing their positions, and 37 closing their positions.
157% more call options, than puts
Call options by funds: $11.7M | Put options by funds: $4.56M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
16% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 68
1% more capital invested
Capital invested by funds: $1.92B → $1.93B (+$10.2M)
5% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 37
3% less funds holding
Funds holding: 226 → 219 (-7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$39M |
| 2 |
Alkeon Capital Management
New York
|
+$34.4M |
| 3 |
Holocene Advisors
New York
|
+$33.3M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$33.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$32.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$32.6M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$14.7M |
| 3 |
Man Group
London,
United Kingdom
|
-$14.6M |
| 4 |
PA
Perceptive Advisors
New York
|
-$12.7M |
| 5 |
APG Asset Management
Amsterdam,
Netherlands
|
-$11.7M |
ARNA Hedge Fund Activity: Q1 2020 in Review
219 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2020, worth a combined $1.93B — up 0.53% from $1.92B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of ARNA and 35 opened new positions — a net loss of 2 holders — while 68 trimmed existing stakes and 79 added.
The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $39M. The largest seller was Primecap Management, cutting an estimated $32.6M.
- 219 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q1 2020, down from 226 in Q4 2019.
- Funds reported $1.93B of Arena Pharmaceuticals Inc stock for Q1 2020, up 0.53% quarter-over-quarter.
- 35 funds opened new Arena Pharmaceuticals Inc positions in Q1 2020 and 37 closed out, a net change of -2 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q1 2020 was Lord, Abbett & Co, an estimated $39M added.
- The largest Arena Pharmaceuticals Inc seller in Q1 2020 was Primecap Management, an estimated $32.6M sold.
Based on aggregated 13F filings for Q1 2020.